Phoenix Financial Ltd (TLV:PHOE)
Israel · Delayed Price · Currency is ILS · Price in ILA 15,660
-220 (-1.39%)
At close: Mar 30, 2026
Phoenix Financial Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 8,360 | 7,779 | 10,356 | 10,567 | 9,816 |
Total Interest & Dividend Income | 7,298 | 5,285 | 2,160 | 2,103 | 14,627 |
Gain (Loss) on Sale of Investments | -9.44 | 30.17 | 6,171 | -4,791 | 13,212 |
Non-Insurance Activities Revenue | - | - | 329 | 223 | 154 |
Other Revenue | 1,380 | 1,181 | 1,096 | 1,007 | -11,886 |
| 19,342 | 16,229 | 21,833 | 10,657 | 27,972 | |
Revenue Growth (YoY) | 19.18% | -25.67% | 104.87% | -61.90% | 67.40% |
Policy Benefits | 6,399 | 6,042 | 17,623 | 1,965 | 21,856 |
Policy Acquisition & Underwriting Costs | - | - | 2,103 | 1,845 | 1,610 |
Selling, General & Administrative | - | - | 2,179 | 1,894 | 1,761 |
Other Operating Expenses | 2,385 | 2,179 | 95.13 | 77.97 | 68.02 |
Total Operating Expenses | 8,784 | 8,220 | 21,999 | 5,782 | 25,295 |
Operating Income | 10,558 | 8,009 | -166.44 | 4,875 | 2,677 |
Interest Expense | -484.58 | -418.87 | -373.3 | -299.37 | -202.75 |
Earnings From Equity Investments | - | - | 42.41 | 61.55 | 111.5 |
Currency Exchange Gain (Loss) | - | - | 1.2 | 124.22 | -27 |
Other Non Operating Income (Expenses) | -5,156 | -3,911 | -30.34 | -0.51 | -9.64 |
EBT Excluding Unusual Items | 4,918 | 3,679 | -526.47 | 4,761 | 2,549 |
Merger & Restructuring Charges | - | - | -11.84 | - | - |
Impairment of Goodwill | -46.44 | - | - | - | - |
Gain (Loss) on Sale of Investments | 150.78 | 2.76 | 1,687 | -2,983 | - |
Gain (Loss) on Sale of Assets | -12.81 | 0.55 | 0.1 | 0 | - |
Asset Writedown | - | -13.87 | -17.31 | 76.65 | 158.68 |
Other Unusual Items | - | -1.27 | 16.11 | - | -9.84 |
Pretax Income | 5,009 | 3,667 | 1,148 | 1,854 | 2,697 |
Income Tax Expense | 1,669 | 1,160 | 262.75 | 504.34 | 673.55 |
Earnings From Continuing Ops. | 3,341 | 2,507 | 884.94 | 1,350 | 2,024 |
Minority Interest in Earnings | -117.97 | -116.05 | -107.53 | -92.82 | -59.22 |
Net Income | 3,223 | 2,391 | 777.4 | 1,257 | 1,965 |
Net Income to Common | 3,223 | 2,391 | 777.4 | 1,257 | 1,965 |
Net Income Growth | 34.78% | 207.57% | -38.16% | -36.01% | 68.06% |
Shares Outstanding (Basic) | 252 | 252 | 253 | 252 | 253 |
Shares Outstanding (Diluted) | 254 | 254 | 256 | 256 | 257 |
Shares Change (YoY) | -0.08% | -0.59% | -0.10% | -0.45% | 0.41% |
EPS (Basic) | 12.78 | 9.49 | 3.07 | 5.00 | 7.76 |
EPS (Diluted) | 12.69 | 9.44 | 3.04 | 4.91 | 7.64 |
EPS Growth | 34.43% | 210.53% | -38.09% | -35.73% | 67.28% |
Free Cash Flow | 3,889 | -1,061 | 1,792 | 2,539 | 4,469 |
Free Cash Flow Per Share | 15.32 | -4.18 | 7.01 | 9.93 | 17.39 |
Dividend Per Share | 5.184 | 3.327 | 1.510 | 1.339 | 2.466 |
Dividend Growth | 55.84% | 120.30% | 12.80% | -45.72% | 65.28% |
Operating Margin | 54.59% | 49.35% | -0.76% | 45.74% | 9.57% |
Profit Margin | 16.66% | 14.73% | 3.56% | 11.80% | 7.02% |
Free Cash Flow Margin | 20.11% | -6.54% | 8.21% | 23.83% | 15.98% |
EBITDA | 10,751 | 8,197 | -60.52 | 5,284 | 3,031 |
EBITDA Margin | 55.59% | 50.51% | -0.28% | 49.58% | 10.84% |
D&A For EBITDA | 193.16 | 188.07 | 105.93 | 408.66 | 354.19 |
EBIT | 10,558 | 8,009 | -166.44 | 4,875 | 2,677 |
EBIT Margin | 54.59% | 49.35% | -0.76% | 45.74% | 9.57% |
Effective Tax Rate | 33.31% | 31.63% | 22.89% | 27.20% | 24.97% |
Revenue as Reported | - | - | 23,539 | 7,906 | 28,099 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.